3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
4
Multiple Myeloma
3
Lymphoma
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Cancers of the Head and Neck
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Mouth Neoplasms
1
Glioma
1
Fanconi Anemia
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Interventions
Trastuzumab
4
tucatinib
3
Capecitabine
3
fludarabine
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
sapanisertib
1
pertuzumab
1
patritumab deruxtecan
1
omburtamab I-131
1
gadopiclenol
1
gadobutrol
1
fludarabine phosphate
1
avelumab
1
aldesleukin
1
Spinal Puncture
1
Specimen Handling
1
Nivolumab
1
Methotrexate
1
Mesna
1
Interleukin-2
1
Blood Specimen Collection
1
AZD1390
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Neoplasms
×
Afatinib
×
1 year
×
Clear all
No trials found.